Literature DB >> 29885455

Bioinformatical identification of key pathways and genes in human hepatocellular carcinoma after CSN5 depletion.

Qiang Fu1, Fan Yang2, Ji Zhao1, Xingxing Yang1, Tengxiao Xiang3, Guoli Huai1, Jiashu Zhang4, Liang Wei1, Shaoping Deng5, Hongji Yang6.   

Abstract

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It has been previously reported that CSN5 depletion is an effective method in human HCC. In the current study, we aimed to uncover gene signatures and key pathways during HCC. Gene expression profiles of GSE26485 were downloaded from GEO database. Totally, 101 differentially expressed genes (DEGs) were up-regulated and 146 ones were down-regulated. Biological processes (BP) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) analysis showed that the DEGs were mainly enriched in regulation of cell growth, oxidation-reduction process, mitotic cytokinesis, negative regulation of macroautophagy, endosome organization, lysosome, biosynthesis of antibiotics, small cell lung cancer and glutathione metabolism and so on (P < 0.05). Protein-protein interaction (PPI) network, Kaplan-Meier, log-rank method, western blot, immunohistochemistry and encyclopedia of DNA elements (ENCODE) analysis showed that CSN5 depletion took effects through down-regulation of SMAD5-related pathways which include EXO1, CENPA and NCAPG, resulting in the inactivation of H3K4me3 and H3K36me3. Those genes represent the promising targets for therapeutic intervention in HCC patients. Published by Elsevier Inc.

Entities:  

Keywords:  Bioinformatics analysis; CSN5 depletion; Differentially expressed gene; Hepatocellular carcinoma; SMAD5

Mesh:

Substances:

Year:  2018        PMID: 29885455     DOI: 10.1016/j.cellsig.2018.06.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  Underlying mechanism of sorafenib resistance in hepatocellular carcinoma: a bioinformatics study based on validated resistance-related genes.

Authors:  Yu Song; Peng Gao; Haiying Ding; Gaoqi Xu; Yan Hu; Yinghui Tong; Wenxiu Xin; Liwen Zhang; Miaolian Wu; Luo Fang
Journal:  J Gastrointest Oncol       Date:  2021-08

2.  Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.

Authors:  Shengjin Cui; Shuang Lou; Jingying Feng; Xi Tang; Xiaowei Xiao; Rong Huang; Weiquan Guo; Yiwen Zhou; Feixia Huang
Journal:  Transl Cancer Res       Date:  2022-04       Impact factor: 1.241

3.  Identification of candidate genes for the diagnosis and treatment of cholangiocarcinoma using a bioinformatics approach.

Authors:  Mi Zhou; Yabin Zhu; Ruixia Hou; Xianbo Mou; Jun Tan
Journal:  Oncol Lett       Date:  2019-09-20       Impact factor: 2.967

4.  Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation.

Authors:  Qiang Fu; Minxue Liao; Cheng Feng; Jichao Tang; Rui Liao; Liang Wei; Hongji Yang; James F Markmann; Kai Chen; Shaoping Deng
Journal:  Aging (Albany NY)       Date:  2019-07-25       Impact factor: 5.682

5.  AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma.

Authors:  Jiaqi Bao; Yanlong Wu; Kun Zhang; Huijuan Qi
Journal:  Int J Gen Med       Date:  2022-08-29

6.  Identification and Analysis of Novel Biomarkers Involved in Chromophobe Renal Cell Carcinoma by Integrated Bioinformatics Analyses.

Authors:  Wei Zhang; Yin Xu; Jinghan Zhang; Jun Wu
Journal:  Biomed Res Int       Date:  2020-02-07       Impact factor: 3.411

7.  Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis.

Authors:  Jinghang Li; Yanxiu Li; Min Jin; Lin Huang; Xiaowei Wang
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.